Chinese Biopharma Firms Chase Hong Kong IPO, After Duality’s Sizzling Debut

All NewsApril 24, 2025

Chinese biopharma firms are actively pursuing Hong Kong IPOs, following the strong debut of Duality Biotherapeutics earlier this month.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent